ArticleRespirology case reports2025
The Diagnostic Dilemma of Incidentally Detected Pulmonary Nodules: A Fatal Case of Pulmonary Epithelioid Hemangioendothelioma.
Article in Respirology case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The Diagnostic Dilemma of Incidentally Detected Pulmonary Nodules: A Fatal Case of Pulmonary Epithelioid Hemangioendothelioma.Respirology case reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pulmonary epithelioid hemangioendothelioma (PEH) is a rare, low- to intermediate-grade malignant vascular tumour. We present a 63-year-old woman with incidentally identified bilateral pulmonary nodules, which demonstrated indolent features on PET-CT (SUVmax 1.8). She returned 4 years later with progressive dyspnoea, a pleural effusion, and radiologic evidence of disease progression. Histopathological examination of a biopsy specimen confirmed PEH, with tumour cells showing positivity for CD31 and a Ki-67 proliferation index of 20%. Despite treatment with a gemcitabine and carboplatin regimen, she developed pleural metastases and succumbed to her disease within a year of diagnosis. This case underscores the potential for aggressive progression in PEH, the prognostic value of the Ki-67 index and the critical need for early histopathological confirmation and more effective therapies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.